Literature DB >> 33237796

Loss of Slfn3 induces a sex-dependent repair vulnerability after 50% bowel resection.

Emilie E Vomhof-DeKrey1, Jack T Lansing1,2, Diane C Darland2, Josey Umthun1,2, Allie D Stover1, Christopher Brown1, Marc D Basson1.   

Abstract

Bowel resection accelerates enterocyte proliferation in the remaining gut with suboptimal absorptive and digestive capacity because of a proliferation-associated decrease in functional differentiation markers. We hypothesized that although schlafen 3 (Slfn3) is an important regulator of enterocytic differentiation, Slfn3 would have less impact on bowel resection adaptation, where accelerated proliferation takes priority over differentiation. We assessed proliferation, cell shedding, and enterocyte differentiation markers from resected and postoperative bowel of wild-type (WT) and Slfn3-knockout (Slfn3KO) mice. Villus length and crypt depth were increased in WT mice and were even longer in Slfn3KO mice. Mitotic marker, Phh3+, and the proliferation markers Lgr5, FoxL1, and platelet-derived growth factor-α (PDGFRα) were increased after resection in male WT, but this was blunted in male Slfn3KO mice. Cell-shedding regulators Villin1 and TNFα were downregulated in female mice and male WT mice only, whereas Gelsolin and EGFR increased expression in all mice. Slfn3 expression increased after resection in WT mice, whereas other Slfn family members 1, 2, 5, 8, and 9 had varied expressions that were affected also by sex difference and loss of Slfn3. Differentiation markers sucrase isomaltase, Dpp4, Glut2, and SGLT1 were all decreased, suggesting that enterocytic differentiation effort is incompatible with rapid proliferation shift in intestinal adaptation. Slfn3 absence potentiates villus length and crypt depth, suggesting that the differentiating stimulus of Slfn3 signaling may restrain mucosal mass increase through regulating Villin1, Gelsolin, EGFR, TNFα, and proliferation markers. Therefore, Slfn3 may be an important regulator not only of "normal" enterocytic differentiation but also in response to bowel resection.NEW & NOTEWORTHY The differentiating stimulus of Slfn3 signaling restrains an increase in mucosal mass after bowel resection, and there is a Slfn3-sex interaction regulating differentiation gene expression and intestinal adaptation. This current study highlights the combinatory effects of gender and Slfn3 genotype on the gene expression changes that contribute to the adaptation in intestinal cellular milleu (i.e. villus and crypt structure) which are utilized to compensate for the stress-healing response that the animals display in intestinal adaptation.

Entities:  

Keywords:  cell shedding; differentiation; intestinal adaptation; proliferation

Mesh:

Substances:

Year:  2020        PMID: 33237796      PMCID: PMC7864235          DOI: 10.1152/ajpgi.00344.2020

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  66 in total

1.  Schlafen, a new family of growth regulatory genes that affect thymocyte development.

Authors:  D A Schwarz; C D Katayama; S M Hedrick
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

Review 2.  Wound healing in the gastrointestinal tract.

Authors:  G W Ellison
Journal:  Semin Vet Med Surg Small Anim       Date:  1989-11

Review 3.  Small bowel adaptation and its regulation.

Authors:  R H Dowling
Journal:  Scand J Gastroenterol Suppl       Date:  1982

4.  Control of Intestinal Epithelial Proliferation and Differentiation: The Microbiome, Enteroendocrine L Cells, Telocytes, Enteric Nerves, and GLP, Too.

Authors:  Jonathan D Kaunitz; Yasutada Akiba
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

5.  Risk factors for short bowel syndrome in patients with Crohn's disease.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Toshihiro Bando; Hiroki Matsuoka; Yoshiko Takahashi; Yoshio Takesue; Takayuki Matsumoto; Naohiro Tomita
Journal:  Surg Today       Date:  2011-12-17       Impact factor: 2.549

6.  Improved survival in a multidisciplinary short bowel syndrome program.

Authors:  Biren P Modi; Monica Langer; Y Avery Ching; Clarissa Valim; Stephen D Waterford; Julie Iglesias; Debora Duro; Clifford Lo; Tom Jaksic; Christopher Duggan
Journal:  J Pediatr Surg       Date:  2008-01       Impact factor: 2.545

7.  Schlafen-3: a novel regulator of intestinal differentiation.

Authors:  Vaishali B Patel; Yingjie Yu; Jayanta K Das; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Biochem Biophys Res Commun       Date:  2009-08-22       Impact factor: 3.575

8.  Schlafen 3 knockout mice display gender-specific differences in weight gain, food efficiency, and expression of markers of intestinal epithelial differentiation, metabolism, and immune cell function.

Authors:  Emilie E Vomhof-DeKrey; Jun Lee; Jack Lansing; Chris Brown; Diane Darland; Marc D Basson
Journal:  PLoS One       Date:  2019-07-01       Impact factor: 3.240

9.  Regulation of epithelial differentiation in rat intestine by intraluminal delivery of an adenoviral vector or silencing RNA coding for Schlafen 3.

Authors:  Pavlo L Kovalenko; Lisi Yuan; Kelian Sun; Lyudmyla Kunovska; Sergey Seregin; Andrea Amalfitano; Marc D Basson
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  Composite Scaffolds Based on Intestinal Extracellular Matrices and Oxidized Polyvinyl Alcohol: A Preliminary Study for a New Regenerative Approach in Short Bowel Syndrome.

Authors:  Francesca Grandi; Elena Stocco; Silvia Barbon; Anna Rambaldo; Martina Contran; Francesco Fascetti Leon; Piergiorgio Gamba; Pier Paolo Parnigotto; Veronica Macchi; Raffaele De Caro; Andrea Porzionato
Journal:  Biomed Res Int       Date:  2018-05-27       Impact factor: 3.411

View more
  1 in total

1.  Vil-Cre specific Schlafen 3 knockout mice exhibit sex-specific differences in intestinal differentiation markers and Schlafen family members expression levels.

Authors:  Emilie E Vomhof-DeKrey; Allie D Stover; Mary Labuhn; Marcus R Osman; Marc D Basson
Journal:  PLoS One       Date:  2021-10-28       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.